鎌状赤血球症治療薬に伴う血管閉塞危機の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE4064)
◆英語タイトル:Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE4064
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:99
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、鎌状赤血球症治療薬に伴う血管閉塞危機の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(SGD-2083、クリザンリズマブ、PF-04447943、NVX-508、その他)、用途別市場規模(クリニック、病院、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・鎌状赤血球症治療薬に伴う血管閉塞危機の市場動向
・企業の競争状況、市場シェア
・鎌状赤血球症治療薬に伴う血管閉塞危機の種類別市場規模(SGD-2083、クリザンリズマブ、PF-04447943、NVX-508、その他)
・鎌状赤血球症治療薬に伴う血管閉塞危機の用途別市場規模(クリニック、病院、その他)
・鎌状赤血球症治療薬に伴う血管閉塞危機の北米市場規模2016-2027(アメリカ、カナダ)
・鎌状赤血球症治療薬に伴う血管閉塞危機の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・鎌状赤血球症治療薬に伴う血管閉塞危機のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・鎌状赤血球症治療薬に伴う血管閉塞危機の中南米市場規模2016-2027(メキシコ、ブラジル)
・鎌状赤血球症治療薬に伴う血管閉塞危機の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(AstraZeneca Plc、Bristol-Myers Squibb Company、Gilead Sciences Inc、Modus Therapeutics Holding AB、Novartis AG、NuvOx Pharma LLC、Pfizer Inc、Seattle Genetics Inc)
・結論
【レポートの概要】

Market Analysis and Insights: Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market
The global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market.

Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Scope and Market Size
Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
SGD-2083
Crizanlizumab
PF-04447943
NVX-508
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca Plc
Bristol-Myers Squibb Company
Gilead Sciences Inc
Modus Therapeutics Holding AB
Novartis AG
NuvOx Pharma LLC
Pfizer Inc
Seattle Genetics Inc

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 SGD-2083
1.2.3 Crizanlizumab
1.2.4 PF-04447943
1.2.5 NVX-508
1.2.6 Others
1.3 Market by Application
1.3.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Perspective (2016-2027)
2.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Growth Trends by Regions
2.2.1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Historic Market Share by Regions (2016-2021)
2.2.3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Forecasted Market Size by Regions (2022-2027)
2.3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Dynamic
2.3.1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Trends
2.3.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Drivers
2.3.3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Challenges
2.3.4 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Players by Revenue
3.1.1 Global Top Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Players by Revenue (2016-2021)
3.1.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share by Players (2016-2021)
3.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue
3.4 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Concentration Ratio
3.4.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in 2020
3.5 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Key Players Head office and Area Served
3.6 Key Players Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Solution and Service
3.7 Date of Enter into Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Breakdown Data by Type
4.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Historic Market Size by Type (2016-2021)
4.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Forecasted Market Size by Type (2022-2027)

5 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Breakdown Data by Application
5.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Historic Market Size by Application (2016-2021)
5.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (2016-2027)
6.2 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type
6.2.1 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021)
6.2.2 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027)
6.2.3 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2027)
6.3 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application
6.3.1 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021)
6.3.2 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027)
6.3.3 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2027)
6.4 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country
6.4.1 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2016-2021)
6.4.2 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (2016-2027)
7.2 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type
7.2.1 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021)
7.2.2 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027)
7.2.3 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2027)
7.3 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application
7.3.1 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021)
7.3.2 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027)
7.3.3 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2027)
7.4 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country
7.4.1 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2016-2021)
7.4.2 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (2016-2027)
8.2 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type
8.2.1 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application
8.3.1 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region
8.4.1 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (2016-2027)
9.2 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type
9.2.1 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021)
9.2.2 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027)
9.2.3 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2027)
9.3 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application
9.3.1 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021)
9.3.2 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027)
9.3.3 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2027)
9.4 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country
9.4.1 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2016-2021)
9.4.2 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (2016-2027)
10.2 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type
10.2.1 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application
10.3.1 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country
10.4.1 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Details
11.1.2 AstraZeneca Plc Business Overview
11.1.3 AstraZeneca Plc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.1.4 AstraZeneca Plc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.1.5 AstraZeneca Plc Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Gilead Sciences Inc
11.3.1 Gilead Sciences Inc Company Details
11.3.2 Gilead Sciences Inc Business Overview
11.3.3 Gilead Sciences Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.3.4 Gilead Sciences Inc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.3.5 Gilead Sciences Inc Recent Development
11.4 Modus Therapeutics Holding AB
11.4.1 Modus Therapeutics Holding AB Company Details
11.4.2 Modus Therapeutics Holding AB Business Overview
11.4.3 Modus Therapeutics Holding AB Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.4.4 Modus Therapeutics Holding AB Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.4.5 Modus Therapeutics Holding AB Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.5.4 Novartis AG Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 NuvOx Pharma LLC
11.6.1 NuvOx Pharma LLC Company Details
11.6.2 NuvOx Pharma LLC Business Overview
11.6.3 NuvOx Pharma LLC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.6.4 NuvOx Pharma LLC Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.6.5 NuvOx Pharma LLC Recent Development
11.7 Pfizer Inc
11.7.1 Pfizer Inc Company Details
11.7.2 Pfizer Inc Business Overview
11.7.3 Pfizer Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.7.4 Pfizer Inc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.7.5 Pfizer Inc Recent Development
11.8 Seattle Genetics Inc
11.8.1 Seattle Genetics Inc Company Details
11.8.2 Seattle Genetics Inc Business Overview
11.8.3 Seattle Genetics Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.8.4 Seattle Genetics Inc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.8.5 Seattle Genetics Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 鎌状赤血球症治療薬に伴う血管閉塞危機の世界市場規模・現状・予測2021年-2027年(Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。